fda changes semaglutide What Patients Need to Know About the GLP-1 Policy does semaglutide cause period issues

To potentially move them into Category 1 or final Bulks List status, the most effective approach is to present a persuasive case for their clinical efficacy and safety to the Pharmacy Compounding Advisory Committee (PCAC) and submit it to the FDA

A study analyzing social media posts about GLP-1 receptor agonists across Reddit, YouTube, and TikTok found that users mentioned sleep-related issues among their top concerns

Common side effects during the first 2-4 weeks include mild nausea, reduced appetite for certain foods, and occasional constipation or diarrhea

In the first half of 2024, LegitScript has seen twice as many violative or problematic ads as it saw in 2023

Ritter is senior consultant of Biologics Consulting Group (Alexandria, VA) and a member of BPIs editorial advisory board